InflaRx IFRX
NASDAQ IFRX
$1.55 +0.00 (+0.32%)
As of: Oct 22, 2026 · 10:49 AM EDT

InflaRx (IFRX) Depreciation & Amortization (CF) (2016 - 2026)

Updated

InflaRx's Depreciation & Amortization (CF) was $107,031 in Q2 2026, down 17.8% from $130,175 a year earlier but up 4.9% from the prior quarter.

Analysis

InflaRx (IFRX) Depreciation & Amortization (CF) (2016 - 2026) Analysis & Trends

On a trailing twelve-month basis, InflaRx's Depreciation & Amortization (CF) was $488.3 billion through Jun 30, 2026, down 5.8% year-over-year; for FY2025, it came in at $473.94 billion, down 8.6% from FY2024.

  • Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 1310.2% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $518.39 billion in FY2024 (-15.1%), $610.9 billion in FY2023 (+0.4%), $608.68 billion in FY2022 (-20.5%) and $765.81 billion in FY2021.
  • Quarterly Depreciation & Amortization (CF) has moved between $102,068 (Q1 2026) and $765.81 billion (Q4 2021) over five years.
  • Compared with a year earlier, Depreciation & Amortization (CF) has declined for ten straight quarters, with an average decline of 12.7% over the last eight quarters.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q3 2023 (growth of 1.7%); the worst was Q3 2022 (a decline of 23.6%).
  • Per Business Quant data, IFRX's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $102,068 (Q1 2026), $488.3 billion (Q4 2025) and $116,664 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,166.78 Bn 1,135.37 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 635.34 Bn 553.86 Bn 17.26 Bn 1.96 Bn
3 AbbVie 503.48 Bn 476.60 Bn 12.70 Bn 194.00 Mn
4 Merck 377.08 Bn 331.46 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 304.13 Bn 268.12 Bn 11.24 Bn -
6 Astrazeneca 267.48 Bn 241.16 Bn 12.86 Bn 1.93 Bn
7 Amgen 241.75 Bn 197.15 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 194.09 Bn 168.29 Bn 6.22 Bn 98.00 Mn
9 Pfizer 172.59 Bn 119.24 Bn 10.94 Bn 1.62 Bn
10 InflaRx 104.63 Mn -228.98 Mn 2.74 Mn 107,031.44
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 107,031.44
Mar 31, 2026 102,067.95
Dec 31, 2025 105,798.75
Sep 30, 2025 116,663.51
Jun 30, 2025 130,175.36
Mar 31, 2025 119,705.50
Dec 31, 2024 118,333.05
Sep 30, 2024 122,391.07
Jun 30, 2024 149,669.07
Mar 31, 2024 134,653.45
Dec 31, 2023 145,824.29
Sep 30, 2023 151,226.99
Jun 30, 2023 158,284.96
Mar 31, 2023 158,821.32
Dec 31, 2022 151,276.16
Sep 30, 2022 148,673.07
Jun 30, 2022 157,443.15
Mar 31, 2022 172,077.94
Dec 31, 2021 190,847.53
Sep 30, 2021 194,610.71
API Access

InflaRx Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=IFRX&period=max&api_key=YOUR_API_KEY